Janney Montgomery Scott LLC Invests $340,000 in Nature's Sunshine Products, Inc. (NASDAQ:NATR)

Janney Montgomery Scott LLC acquired a new position in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 27,108 shares of the company's stock, valued at approximately $340,000. Janney Montgomery Scott LLC owned approximately 0.15% of Nature's Sunshine Products as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Wells Fargo & Company MN raised its position in Nature's Sunshine Products by 28.8% in the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock worth $106,000 after acquiring an additional 1,611 shares in the last quarter. Barclays PLC boosted its holdings in shares of Nature's Sunshine Products by 5.9% during the fourth quarter. Barclays PLC now owns 37,693 shares of the company's stock worth $552,000 after purchasing an additional 2,091 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Nature's Sunshine Products by 2,090.2% during the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock worth $28,000 after purchasing an additional 2,132 shares during the last quarter. Russell Investments Group Ltd. purchased a new position in shares of Nature's Sunshine Products in the 4th quarter worth $41,000. Finally, Northern Trust Corp raised its position in Nature's Sunshine Products by 2.7% in the fourth quarter. Northern Trust Corp now owns 119,005 shares of the company's stock valued at $1,745,000 after purchasing an additional 3,174 shares during the period. 79.40% of the stock is owned by institutional investors and hedge funds.

Nature's Sunshine Products Stock Up 2.8%

NATR stock traded up $0.43 during midday trading on Monday, reaching $16.02. The company had a trading volume of 168,196 shares, compared to its average volume of 51,232. The stock has a 50 day moving average price of $14.37 and a 200 day moving average price of $13.88. Nature's Sunshine Products, Inc. has a fifty-two week low of $10.81 and a fifty-two week high of $18.06. The firm has a market capitalization of $295.73 million, a PE ratio of 30.23 and a beta of 1.14.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.25 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.09. Nature's Sunshine Products had a return on equity of 6.98% and a net margin of 2.22%. The company had revenue of $113.25 million during the quarter, compared to the consensus estimate of $109.39 million.

Wall Street Analysts Forecast Growth

Separately, DA Davidson reaffirmed a "buy" rating and set a $19.00 target price on shares of Nature's Sunshine Products in a research report on Tuesday, June 3rd.

Insider Activity

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the business's stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $11.46, for a total transaction of $32,713,796.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 5.60% of the company's stock.

Nature's Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.